Antiviral drug strategies / (Record no. 18482)

MARC details
000 -LEADER
fixed length control field 04924cam a2200673Ii 4500
001 - CONTROL NUMBER
control field ocn729726279
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220701010824.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cn|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 110609s2011 gw a ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency DG1
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency DG1
Modifying agency YDXCP
-- CDX
-- OCLCQ
-- E7B
-- N$T
-- SCB
-- OCLCQ
-- MHW
-- OTZ
-- IDEBK
-- OCLCQ
-- NLGGC
-- OCLCQ
-- COO
-- OCLCQ
-- TMC
-- D6H
019 ## -
-- 740225701
-- 741454003
-- 778454561
-- 781264224
-- 785512762
-- 816845214
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9783527635955
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 3527635955
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9783527635979
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 3527635971
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1283140918
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781283140911
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9783527326969
Qualifying information (hbk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 3527326960
Qualifying information (hbk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9783527635962
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 3527635963
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9783527635986
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 352763598X
024 8# - OTHER STANDARD IDENTIFIER
Standard number or code 9786613140913
029 1# - (OCLC)
OCLC library identifier AU@
System control number 000047551108
029 1# - (OCLC)
OCLC library identifier NZ1
System control number 14693860
029 1# - (OCLC)
OCLC library identifier NZ1
System control number 15915098
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)729726279
Canceled/invalid control number (OCoLC)740225701
-- (OCoLC)741454003
-- (OCoLC)778454561
-- (OCoLC)781264224
-- (OCoLC)785512762
-- (OCoLC)816845214
037 ## - SOURCE OF ACQUISITION
Stock number 10.1002/9783527635955
Source of stock number/acquisition Wiley InterScience
Note http://www3.interscience.wiley.com
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RS431.A66
Item number A68 2011
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV268.5
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 071000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.7924
Edition number 22
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Antiviral drug strategies /
Statement of responsibility, etc edited by Erik De Clercq.
264 #1 -
-- Weinheim :
-- Wiley-VCH ;
-- Chichester :
-- John Wiley [distributor],
-- 2011.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xx, 406 pages) :
Other physical details illustrations (some color).
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
490 1# - SERIES STATEMENT
Series statement Methods and principles in medicinal chemistry ;
Volume number/sequential designation v. 50
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 00 - FORMATTED CONTENTS NOTE
Title Outlook of the antiviral drug era, now more than 50 years after description of the first antiviral drug /
Statement of responsibility Erik De Clercq --
Title Inhibition of HIV entry /
Statement of responsibility José A. Esté --
Title Targeting integration beyond strand transfer: development of second-generation HIV integrase inhibitors /
Statement of responsibility Arnout R.D. Voet,
-- Marc De Maeyer,
-- Frauke Christ,
-- Zeger Debyser --
Title From saquinavir to darunavir: the impact of 10 years of medicinal chemistry on a lethal disease /
Statement of responsibility Marie-Pierre de Béthune,
-- Anik Peeters,
-- Piet Wigerinck --
Title Acyclic and cyclic nucleoside phosphonates /
Statement of responsibility Richard L. Mackman,
-- Tomas Cihlar --
Title Helicase-primase inhibitors: a new approach to combat herpes simplex virus and varicella zoster virus /
Statement of responsibility Subhajit Biswas,
-- Hugh J. Field --
Title Cyclophilin inhibitors /
Statement of responsibility Grégoire Vuagniaux,
-- Arnaud Hamel,
-- Rafael Crabbé,
-- Hervé C. Porchet,
-- Jean-Maurice Dumont --
Title Alkoxyalkyl ester prodrugs of antiviral nucleoside phosphates and phosphonates /
Statement of responsibility James R. Beadle,
-- Karl Y. Hostetler --
Title Maribavir: a novel benzimidazole ribonucleoside for the prevention and treatment of cytomegalovirus diseases /
Statement of responsibility Karen K. Biron --
Title Anti-HCMV compounds /
Statement of responsibility Graciela Andrei,
-- Robert Snoeck --
Title Lethal mutagenesis as an unconventional approach to combat HIV /
Statement of responsibility Pinar Iyidogan,
-- Karen S. Anderson --
Title Recent progress in the development of HCV protease inhibitors /
Statement of responsibility Nagraj Mani,
-- Bhisetti G. Rao,
-- Tara L. Kieffer,
-- Ann D. Kwong --
Title Antiviral RNAi: how to silence viruses /
Statement of responsibility Karin J. von Eije,
-- Ben Berkhout --
Title Neuraminidase inhibitors as anti-influenza agents /
Statement of responsibility Willard Lew,
-- Michael Z. Wang,
-- Xiaowu Chen,
-- James F. Rooney,
-- Choung Kim --
Title From TIBO to rilpivirine: the chronicle of the discovery of the ideal nonnucleoside reverse transcriptase inhibitor /
Statement of responsibility Erik De Clercq.
588 0# -
-- Print version record.
520 ## - SUMMARY, ETC.
Summary, etc By focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, this ready reference provides the critical knowledge needed to develop entirely novel therapeutics and to target new viruses. It begins with a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases, neuraminidases, RNA polymerases, helicases and primases, as well as their known inhibitors. The final section contains several cases studies of recent successful antiviral drug development. Edited by Erik de.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Antiviral agents
General subdivision Development.
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Antiviral agents
General subdivision Development.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacology.
Source of heading or term bisacsh
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Antiviral Agents.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug Discovery.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name De Clercq, Erik.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Print version:
Title Antiviral drug strategies.
Place, publisher, and date of publication Weinheim : Wiley-VCH ; Chichester : John Wiley [distributor], 2011
International Standard Book Number 9783527326969
Record control number (OCoLC)664325845
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Methods and principles in medicinal chemistry ;
Volume number/sequential designation v. 50.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://dx.doi.org/10.1002/9783527635955">http://dx.doi.org/10.1002/9783527635955</a>
Public note Wiley Online Library
994 ## -
-- 92
-- DG1

No items available.